In a group of 100 patients, a quercetin ingredient marketed by Indena was linked to milder symptoms and faster conversion from positive to negative tests.
The site will focus on pharmaceutical and nutraceutical trials on cardiovascular disease, hypertension, dyslipidemia, diabetes, IBS, and weight management.
Compared to a standard caffeine supplement, Nutriventia’s CaffXtend resulted in a longer peak time, and significant improvements in self-reported effects.